Immunity to Visceral Leishmaniasis Using Genetically Defined Live-Attenuated Parasites
Leishmaniasis is a protozoan parasitic disease endemic to the tropical and subtropical regions of the world, with three major clinical forms, self-healing cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and visceral leishmaniasis (VL). Drug treatments are expensive and often result...
Saved in:
| Main Authors: | Angamuthu Selvapandiyan, Ranadhir Dey, Sreenivas Gannavaram, Ines Lakhal-Naouar, Robert Duncan, Poonam Salotra, Hira L. Nakhasi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Journal of Tropical Medicine |
| Online Access: | http://dx.doi.org/10.1155/2012/631460 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Downregulation of IRF7-mediated type-I interferon response by LmCen –/– parasites is necessary for protective immunity
by: Telly Sepahpour, et al.
Published: (2024-12-01) -
An Update on Clinical and Pathogenic Spectra of Leishmaniasis
by: Angamuthu Selvapandiyan, et al.
Published: (2025-01-01) -
Visceral leishmaniasis: Recent updates
by: Jaya Chakravarty, et al.
Published: (2025-06-01) -
Epidemiology of visceral leishmaniasis in Georgia.
by: Giorgi Babuadze, et al.
Published: (2014-03-01) -
Low parasite load estimated by qPCR in a cohort of children living in urban area endemic for visceral leishmaniasis in Brazil.
by: Letícia Helena dos Santos Marques, et al.
Published: (2012-01-01)